Work

Phase I Trial of CCL21 Gene Modified Dendritic Cells in Lung Cancer Elicits Immune Responses

Year: 2017

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.06.024

Authors: J.M. Lee, E.B. Garon, J.W. Goldman, F. Abtin, R. Suh, W.D. Wallace, G. Zeng, D.A. Elashoff, S. Sharma, S.M. Dubinett

Institution: University of California, Los Angeles

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2737563152

FWCI:

Cites:

Cited by: 1

Related to: 10